Evidence map›Paper›PMID 3005468›Full record

ArticleThe Journal of experimental medicine1986

Identification of a second class of IgG Fc receptors on human neutrophils. A 40 kilodalton molecule also found on eosinophils.

R J Looney, D H Ryan, K Takahashi, H B Fleit, H J Cohen, G N Abraham, C L Anderson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1986. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 139 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Fc receptor-mediated signal transduction.Journal of clinical immunology · 1994
    Review
  14. Fc gamma RI and Fc gamma RIII on polymorphonuclear leucocytes in cord blood.Archives of disease in childhood. Fetal and neonatal edition · 1994
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

R J Looney
D H Ryan
K Takahashi
H B Fleit
H J Cohen
G N Abraham
C L Anderson
State University of New York · US

Funding

WHITE BLOOD CELL OXIDASE--NORMAL AND ABNORMALR01AI019656 · NIAID · UNIVERSITY OF ROCHESTER · PI COHEN, HARVEY J · 1985 to 1992
–
SELENIUM NUTRITION - EFFECTS ON BLOOD CELL FUNCTIONR01AM033231 · AM · UNIVERSITY OF ROCHESTER · PI COHEN, HARVEY J · 1985 to 1985
–
FC RECEPTOR STRUCTURE AND FUNCTIONR01CA024067 · NCI · UNIVERSITY OF ROCHESTER · PI ANDERSON, CLARK L · 1985 to 1985
–
NCI NIH HHS R01-CA24067NIADDK NIH HHS R01-AM33231NIAID NIH HHS R01-AI19656
6 · The paper itself

Abstract

We describe a newly recognized 40 kD FcR for IgG on human neutrophilic granulocytes. An mAb (IV3) developed against the IgG FcR of K562 cells, and specific as well for a 40 kD FcR on human monocytes and platelets, was found to purify by affinity adsorption a 40 kD protein from detergent lysates of surface-radioiodinated neutrophils. This protein, proteolytically degraded to 33 kD when purified in the absence of diisopropylfluorophosphate, is distinct from the 51-73 kD protein precipitated by the anti-neutrophil FcR mAb, 3G8, previously described by others. Complete inhibition of binding of rabbit IgG-coated erythrocytes to neutrophils was achieved only when both antibodies, IV3 and 3G8, were used. Fab fragments of IV3 were as effective inhibitors as the intact molecule. IV3 IgG or Fab fragments completely and selectively inhibited immune complex-mediated generation of superoxide by human neutrophils; superoxide generation by other stimulants was not abrogated by IV3. This antibody (IV3) bound also to human eosinophils and completely inhibited the binding of IgG-coated erythrocytes to eosinophils. IV3 appears to define the human homolog of the murine macrophage FcRII identified initially by mAb 2.4G2 and present in the mouse on both neutrophils and eosinophils.

Indexed as

Antibodies, MonoclonalAntigen-Antibody ComplexEosinophilsFlow CytometryHumansImmunoglobulin Fab FragmentsImmunoglobulin GNeutrophilsReceptors, FcRosette FormationSuperoxidesAntibodies, MonoclonalAntigen-Antibody ComplexImmunoglobulin Fab FragmentsImmunoglobulin GReceptors, FcSuperoxides

Identifiers

PMID3005468
PMCPMC2188084
OpenAlexW2156000670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.